RDA Financial Network Has $2.90 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

RDA Financial Network raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.7% during the 2nd quarter, Holdings Channel.com reports. The firm owned 8,465 shares of the medical equipment provider’s stock after acquiring an additional 532 shares during the period. Intuitive Surgical accounts for 1.2% of RDA Financial Network’s investment portfolio, making the stock its 20th biggest position. RDA Financial Network’s holdings in Intuitive Surgical were worth $2,895,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. HHM Wealth Advisors LLC raised its stake in Intuitive Surgical by 1,314.3% during the 1st quarter. HHM Wealth Advisors LLC now owns 99 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 92 shares during the period. Bogart Wealth LLC increased its stake in shares of Intuitive Surgical by 721.4% in the first quarter. Bogart Wealth LLC now owns 115 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 101 shares during the last quarter. Barrett & Company Inc. acquired a new position in shares of Intuitive Surgical in the first quarter worth $30,000. Strategic Investment Solutions Inc. IL acquired a new position in shares of Intuitive Surgical in the first quarter worth $39,000. Finally, Addison Advisors LLC increased its stake in shares of Intuitive Surgical by 1,837.5% in the first quarter. Addison Advisors LLC now owns 155 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 147 shares during the last quarter. 82.91% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $305.68, for a total transaction of $152,840.00. Following the completion of the sale, the director now owns 702 shares of the company’s stock, valued at $214,587.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, EVP Robert Desantis sold 2,535 shares of the stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $323.26, for a total transaction of $819,464.10. Following the sale, the executive vice president now directly owns 7,259 shares of the company’s stock, valued at $2,346,544.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amy L. Ladd sold 500 shares of the stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $305.68, for a total transaction of $152,840.00. Following the sale, the director now directly owns 702 shares in the company, valued at $214,587.36. The disclosure for this sale can be found here. Insiders sold 60,309 shares of company stock valued at $19,649,321 over the last quarter. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. Truist Financial upped their price target on shares of Intuitive Surgical from $347.00 to $400.00 in a research note on Wednesday, July 19th. Barclays upped their price objective on shares of Intuitive Surgical from $314.00 to $385.00 and gave the stock an “overweight” rating in a report on Monday, July 24th. Piper Sandler upped their price objective on shares of Intuitive Surgical from $315.00 to $385.00 and gave the stock an “overweight” rating in a report on Friday, July 21st. Mizuho upped their price objective on shares of Intuitive Surgical from $300.00 to $370.00 in a report on Monday, July 17th. Finally, BTIG Research upped their price target on shares of Intuitive Surgical from $326.00 to $373.00 in a report on Monday, July 17th. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $343.10.

Intuitive Surgical Trading Up 0.6 %

NASDAQ:ISRG traded up $1.81 during mid-day trading on Tuesday, hitting $299.98. The company’s stock had a trading volume of 575,601 shares, compared to its average volume of 1,695,594. Intuitive Surgical, Inc. has a fifty-two week low of $180.07 and a fifty-two week high of $358.07. The company has a market capitalization of $105.41 billion, a price-to-earnings ratio of 74.73, a P/E/G ratio of 4.15 and a beta of 1.30. The stock has a fifty day moving average of $314.56 and a 200-day moving average of $298.07.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.09. Intuitive Surgical had a net margin of 21.38% and a return on equity of 12.41%. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the prior year, the business posted $0.85 earnings per share. The company’s quarterly revenue was up 15.4% compared to the same quarter last year. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 4.53 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.